Intel, ConsenSys Health combine blockchain and AI for clinical trials management
Healthcare IT News October 7, 2021
The vendors discovered that distributed ledger technology was much faster and more efficient, while maintaining necessary privacy and security.
Matching patients to clinical trials they are eligible for has been a major challenge for everyone from pharmaceutical companies to hospitals.
THE PROBLEM
Finding the right matches based on certain health records and demographic eligibility is difficult and time-consuming. It costs a lot of money, can slow clinical trials down and is one of the major reasons trials fail. This slows down progress in advancing new medical treatments and advancing health outcomes.
“On the flip side, patients want to be involved in trials, but often can’t find the right ones,” said Sean T. Manion, chief scientific officer at New York City-based...